Published in Semin Liver Dis on October 19, 2010
Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol (2011) 1.52
Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol (2012) 1.37
Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol (2013) 1.35
Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice. Hepatology (2011) 1.23
Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. J Lipid Res (2011) 1.21
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol (2014) 1.02
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.00
Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol (2011) 0.98
Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis. Sci Rep (2014) 0.92
Schisandra chinensis prevents alcohol-induced fatty liver disease in rats. J Med Food (2014) 0.87
CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis. J Lipid Res (2013) 0.86
Steatosis and steatohepatitis: complex disorders. Int J Mol Sci (2014) 0.83
The inhibitory effect of ethanol on Sestrin3 in the pathogenesis of ethanol-induced liver injury. Am J Physiol Gastrointest Liver Physiol (2014) 0.82
Alcoholic-induced hepatic steatosis--role of ceramide and protein phosphatase 2A. Transl Res (2011) 0.82
Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity. J Biol Chem (2016) 0.81
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. FASEB J (2014) 0.81
Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol Clin Exp Res (2012) 0.81
Time-dependent changes in lipid metabolism in mice with methionine choline deficiency-induced fatty liver disease. Mol Cells (2011) 0.80
Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2015) 0.79
Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J Hepatol (2015) 0.79
Effects of Age, Sex, Body Weight, and Quantity of Alcohol Consumption on Occurrence and Severity of Alcoholic Hepatitis. Clin Gastroenterol Hepatol (2016) 0.78
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis. Sci Rep (2016) 0.78
Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment. PLoS One (2015) 0.78
Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp). J Investig Med (2016) 0.76
Lipid droplet-associated proteins in alcoholic liver disease: a potential linkage with hepatocellular damage. Int J Clin Exp Pathol (2015) 0.76
Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced Steatohepatitis. J Clin Exp Pathol (2012) 0.76
Dissociation between diurnal cycles in locomotor activity, feeding behavior and hepatic PERIOD2 expression in chronic alcohol-fed mice. Alcohol (2015) 0.76
Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression. J Biol Chem (2016) 0.76
Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC. J Investig Med (2016) 0.76
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease. World J Gastroenterol (2016) 0.76
Topological and functional analysis of nonalcoholic steatohepatitis through protein interaction mapping. Gastroenterol Hepatol Bed Bench (2016) 0.75
New treatment options for alcoholic hepatitis. World J Gastroenterol (2016) 0.75
The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liver. Curr Mol Pharmacol (2015) 0.75
Mechanisms Involved in Disruption of Adipose Tissue Mass Resulting from Chronic Unhealthy Alcohol Consumption. Alcohol Clin Exp Res (2016) 0.75
Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology (2016) 0.75
Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association. Oxid Med Cell Longev (2017) 0.75
The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol (2013) 2.21
Endoscopic therapy with 2-octyl-cyanoacrylate for the treatment of gastric varices. Dig Dis Sci (2014) 1.99
The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J Clin Gastroenterol (2014) 1.57
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology (2008) 1.53
Racial disparities in gastrointestinal cancers-related mortality in the U.S. population. Dig Dis Sci (2012) 1.44
Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol (2007) 1.24
Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists. Clin Gastroenterol Hepatol (2003) 1.22
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study. Am J Gastroenterol (2010) 1.19
Validation of a multivariate model predicting presence and size of varices. J Clin Gastroenterol (2007) 1.15
Alcohol and lipid metabolism. J Gastroenterol Hepatol (2006) 1.11
Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci (2008) 1.10
Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis (2004) 1.09
Ethanol-induced alterations in fatty acid-related lipids in serum and tissues in mice. Alcohol Clin Exp Res (2010) 1.05
Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep (2008) 1.03
Preprocedure patient values regarding sedation for colonoscopy. J Clin Gastroenterol (2005) 1.02
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression. Clin Pharmacol Ther (2005) 0.99
Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.97
Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol (2015) 0.93
Chronic free-choice drinking in crossed high alcohol preferring mice leads to sustained blood ethanol levels and metabolic tolerance without evidence of liver damage. Alcohol Clin Exp Res (2012) 0.91
Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes. Novartis Found Symp (2007) 0.89
Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors. Arch Biochem Biophys (2002) 0.86
Alcohol metabolism in human cells causes DNA damage and activates the Fanconi anemia-breast cancer susceptibility (FA-BRCA) DNA damage response network. Alcohol Clin Exp Res (2011) 0.86
A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MS. Electrophoresis (2009) 0.85
Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transpl (2004) 0.85
Ethanol metabolism by HeLa cells transduced with human alcohol dehydrogenase isoenzymes: control of the pathway by acetaldehyde concentration. Alcohol Clin Exp Res (2011) 0.84
Ethanol impairs differentiation of human adipocyte stromal cells in culture. Alcohol Clin Exp Res (2011) 0.83
Association between metabolic syndrome and its individual components with viral hepatitis B. Am J Med Sci (2014) 0.83
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study. Alcohol Clin Exp Res (2015) 0.83
Alcoholic-induced hepatic steatosis--role of ceramide and protein phosphatase 2A. Transl Res (2011) 0.82
Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med (2012) 0.80
Adult diffuse hepatic hemangiomatosis: a rare cause of dilated cardiomyopathy and sudden cardiac arrest. J Gen Intern Med (2013) 0.79
Fatal case of babesiosis in postliver transplant patient. Transplantation (2009) 0.79
Identification of a retinoid receptor response element in the human aldehyde dehydrogenase-2 promoter. Alcohol Clin Exp Res (2003) 0.79
Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding. Clin Lymphoma Myeloma (2008) 0.79
Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation. Liver Transpl (2014) 0.79
Past exposure to hepatitis B: a risk factor for increase in mortality? J Clin Gastroenterol (2014) 0.77
Alcohol exposure rate control through physiologically based pharmacokinetic modeling. Alcohol Clin Exp Res (2012) 0.77
What advice should be given to patients with NAFLD about the consumption of alcohol? Nat Clin Pract Gastroenterol Hepatol (2008) 0.76
Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis. J Clin Gastroenterol (2016) 0.76
Screening, Brief Intervention, Referral to Treatment (SBIRT), and Motivational Interviewing for PGY-1 Medical Residents. J Grad Med Educ (2014) 0.75
Proteomic profiling of human sera for discovery of potential biomarkers to monitor abstinence from alcohol abuse. Electrophoresis (2015) 0.75
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population. J Clin Gastroenterol (2016) 0.75
Role of hemoclips in the management of acute bleeding from a gastric stromal tumor: a case report and review of the literature. J Med Case Rep (2007) 0.75
Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006. J Clin Gastroenterol (2016) 0.75
Relationship between serum leptin and chronic obstructive pulmonary disease in US adults: results from the third National Health and Nutrition Examination Survey. J Investig Med (2014) 0.75
Reply to Martinez-Gonzalez et al. Dig Dis Sci (2015) 0.75
Metabolic syndrome following liver transplantation is associated with major vascular events. Liver Transpl (2007) 0.75
Animal models of alcoholic liver disease: Pathogenesis and clinical relevance. Gene Expr (2017) 0.75
Watermelon colon treated by argon plasma coagulation. Gastrointest Endosc (2005) 0.75
Forestier disease: a rare cause of dysphagia. Clin Gastroenterol Hepatol (2008) 0.75